Clinical Trial Update: Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing FIAsp-based basal-bolus regimen to basal insulin therapy, both with metformin, in adults with type 2 diabetes; study completed with post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Fiasp (insulin aspart)
• Insulin (insulin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2018-01-17